Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2

Oncotarget

Volumn 7, Issue 50, 2016, Pages 83588-83600

  Feng, Weijing ^a   Zhang, Kun ^a   Liu, Yu ^b   Chen, Jie ^a,c   Cai, Qingqing ^d   Zhang, Yinyin ^a   Wang, Mongheng ^e   Wang, Jingfeng ^a   Huang, Hui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin II; Apocynin; Osteogenic switching; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; APOCYNIN; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; GLYCEROL 2 PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOPONTIN; SMOOTH MUSCLE 22 ALPHA; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ACETOPHENONE DERIVATIVE; MAPK1 PROTEIN, HUMAN; MAPK1 PROTEIN, RAT;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; AGED; ANIMAL; BLOOD; BONE DEVELOPMENT; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ACETOPHENONES; AGED; ANGIOTENSIN II; ANIMALS; ANKLE BRACHIAL INDEX; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOGENESIS; PHENOTYPE; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

EID: 85003819955     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.13193     Document Type: Article

References (37)

1. Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vascular health and risk management. 2009; 5:185-197.
2. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison MA. Blood pressure and vascular calcification. Hypertension. 2010; 55:990-997.
3. Anand DV, Lim E, Darko D, Bassett P, Hopkins D, Lipkin D, Corder R, Lahiri A. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. Journal of the American College of Cardiology. 2007; 50:2218-2225.
4. van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nature reviews Cardiology. 2009; 6:580-589.
5. Garland JS, Holden RM, Groome PA, Lam M, Nolan RL, Morton AR, Pickett W. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. American journal of kidney diseases. 2008; 52:849-858.
6. Liu ZH, the China Dialysis Calcification Study G. Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study. BMC nephrology. 2015; 16:129.
7. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nature reviews Cardiology. 2010; 7:528-536.
8. Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol. 2012; 8:529-543.
9. Jia G, Stormont RM, Gangahar DM, Agrawal DK. Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification. American journal of physiology Heart and circulatory physiology. 2012; 303:H523-532.
10. Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P, Huang W, Liu YS. The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs. Int J Cardiol. 2015; 189:188-193.
11. Sun Y, Byon CH, Yuan K, Chen J, Mao X, Heath JM, Javed A, Zhang K, Anderson PG, Chen Y. Smooth muscle cellspecific runx2 deficiency inhibits vascular calcification. Circ Res. 2012; 111:543-552.
12. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, van Leeuwen FN, Touyz RM. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010; 56:453-462.
13. Montezano AC, Nguyen Dinh Cat A, Rios FJ, Touyz RM. Angiotensin II and vascular injury. Current hypertension reports. 2014; 16:431.
14. Zhang Z, Wang M, Fan XH, Chen JH, Guan YY, Tang YB. Upregulation of TRPM7 Channels by Angiotensin II Triggers Phenotypic Switching of Vascular Smooth Muscle Cells of Ascending Aorta. Circ Res. 2012; 111:1137-U1199.
15. Ye S, Lowther S, Stambas J. Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3. Journal of virology. 2015; 89:2672-2683.
16. Wallace K, Cornelius DC, Scott J, Heath J, Moseley J, Chatman K, LaMarca B. CD4(+) T Cells Are Important Mediators of Oxidative Stress That Cause Hypertension in Response to Placental Ischemia. Hypertension. 2014; 64:1151-8.
17. Simonyi A, Serfozo P, Lehmidi TM, Cui J, Gu Z, Lubahn DB, Sun AY, Sun GY. The neuroprotective effects of apocynin. Frontiers in bioscience. 2012; 4:2183-2193.
18. Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33:777-784.
19. Zhang K, Liu Y, Liu X, Chen J, Cai Q, Wang J, Huang H. Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids. Oncotarget. 2015; 6:24699-24708 doi: 10.18632/oncotarget.5084.
20. Liu Y, Liu Y, Liu X, Chen J, Zhang K, Huang F, Wang JF, Tang W, Huang H. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition. Journal of the American Heart Association. 2015; 4.
21. Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL. Overexpression of C1q/Tumor Necrosis Factor-Related Protein-3 Promotes Phosphate-Induced Vascular Smooth Muscle Cell Calcification Both In Vivo and In Vitro. Arterioscl Throm Vas. 2014; 34:1002-1010.
22. Jimbo R, Kawakami-Mori F, Mu SY, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T. Fibroblast growth factor 23 accelerates phosphateinduced vascular calcification in the absence of Klotho deficiency. Kidney international. 2014; 85:1103-1111.
23. Adragao T, Pires A, Branco P, Castro R, Oliveira A, Nogueira C, Bordalo J, Curto JD, Prata MM. Ankle-brachial index, vascular calcifications and mortality in dialysis patients. Nephrology, dialysis, transplantation. 2012; 27:318-325.
24. Wang L, Zheng J, Du Y, Huang Y, Li J, Liu B, Liu CJ, Zhu Y, Gao Y, Xu Q, Kong W, Wang X. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7) beta(1) integrin. Circ Res. 2010; 106:514-525.
25. Mouzaoui S, Djerdjouri B, Makhezer N, Kroviarski Y, El-Benna J, Dang PM. Tumor necrosis factor-alpha-induced colitis increases NADPH oxidase 1 expression, oxidative stress, and neutrophil recruitment in the colon: preventive effect of apocynin. Mediators of inflammation. 2014; 2014:312484.
26. Khanicheh E, Qi Y, Xie A, Mitterhuber M, Xu L, Mochizuki M, Daali Y, Jaquet V, Krause KH, Ruggeri ZM, Kuster GM, Lindner JR, Kaufmann BA. Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33:2187-2192.
27. Brodeur MR, Bouvet C, Barrette M, Moreau P. Palmitic acid increases medial calcification by inducing oxidative stress. Journal of vascular research. 2013; 50:430-441.
28. Zhang Y, Naggar JC, Welzig CM, Beasley D, Moulton KS, Park HJ, Galper JB. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arteriosclerosis, thrombosis, and vascular biology. 2009; 29:1764-1771.
29. Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC, Sibinga NE. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J Mol Cell Cardiol. 2014; 66:18-26.
30. Huang J, Huang H, Wu M, Li J, Xie H, Zhou HD, Liao EY, Peng YQ. Connective tissue growth factor induces osteogenic differentiation of vascular smooth muscle cells through ERK signaling. Int J Mol Med. 2013; 32:423-429.
31. Armstrong ZB, Boughner DR, Drangova M, Rogers KA. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovascular research. 2011; 90:165-170.
32. Zhang Y, Chen J, Zhang K, Kong M, Wang T, Chen R, Wang L, Wang J, Huang H. Inflammation and oxidative stress are associated with the prevalence of high aanklebrachial index in metabolic syndrome patients without chronic renal failure. International journal of medical sciences. 2013; 10:183-190.
33. Chen R, He W, Zhang K, Zheng H, Lin L, Nie R, Wang J, Huang H. Airflow obstruction was associated with elevation of brachial-ankle pulse wave velocity but not ankle-brachial index in aged patients with chronic obstructive pulmonary disease. Atherosclerosis. 2015; 242:135-140.
34. Ix JH, Miller RG, Criqui MH, Orchard TJ. Test characteristics of the ankle-brachial index and anklebrachial difference for medial arterial calcification on X-ray in type 1 diabetes. Journal of vascular surgery. 2012; 56:721-727.
35. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology. 1990; 15:827-832.
36. Cardus A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso JM. 1, 25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney international. 2006; 69:1377-1384.
37. Zhang K, Cheng G, Cai X, Chen J, Jiang Y, Wang T, Wang J, Huang H. Malnutrition, a new inducer for arterial calcification in hemodialysis patients? Journal of translational medicine. 2013; 11:66.